Reported Late Wednesday March 08, Neoleukin Therapeutics Provides Strategic Update And Announces Restructuring And Leadership Transition; Chief Executive Officer Jonathan Drachman, M.D., Will Be Stepping Down After A Short Transition

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!